Comparison
5p Partial Monosomy Syndrome C0010314 vs 17 20 Lyase Deficiency Isolated Included CN372394
Clinical comparison between 5P Partial Monosomy Syndrome and 17 20 Lyase Deficiency Isolated Included CN372394 for differential diagnosis and treatment planning.
6 comparison axes
Onset
5p Partial Monosomy Syndrome C0010314
0-0
17 20 Lyase Deficiency Isolated Included CN372394
0-16
Onset patterns differ
Severity
5p Partial Monosomy Syndrome C0010314
severe
17 20 Lyase Deficiency Isolated Included CN372394
severe
Different severity levels
Chronic
5p Partial Monosomy Syndrome C0010314
Chronic
17 20 Lyase Deficiency Isolated Included CN372394
Chronic
Differing course
Communicable
5p Partial Monosomy Syndrome C0010314
No
17 20 Lyase Deficiency Isolated Included CN372394
No
Different transmission
Body System
5p Partial Monosomy Syndrome C0010314
congenital
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
Same/different system
Category
5p Partial Monosomy Syndrome C0010314
genetic
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
Different category
Bottom line
5p-partial-monosomy-syndrome-C0010314 and 17-20-lyase-deficiency-isolated-included-CN372394 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 5p Partial Monosomy Syndrome C0010314 | 17 20 Lyase Deficiency Isolated Included CN372394 | Discriminating power |
|---|---|---|---|
| Early cry and development | High-pitched cry and developmental delay may be present from infancy. | A characteristic cry or primary neurodevelopmental syndrome is not established. | High |
| Sex development | Disordered sex development is not a defining feature. | Undervirilization, absent puberty, or infertility may occur; expression varies. | High |
| Physical pattern | Congenital growth and craniofacial differences may accompany intellectual disability. | The main pattern is endocrine rather than a multisystem deletion syndrome. | Moderate |
When to favor each condition
Choose 5p Partial Monosomy Syndrome C0010314 when
Infant with cat-like cry and delay
This pattern supports chromosomal evaluation for 5p deletion.
High
Confirmed chromosome 5p deletion
Genetic confirmation distinguishes it from an endocrine enzyme disorder.
High
Congenital dysmorphism with intellectual disability
The overall congenital pattern fits better than isolated steroid deficiency.
Moderate
Choose 17 20 Lyase Deficiency Isolated Included CN372394 when
46,XY undervirilization or absent puberty
Sex-steroid deficiency should prompt specialist endocrine assessment.
Moderate
Abnormal sex-steroid pathway with preserved cortisol concern
This may suggest isolated lyase deficiency, but combined defects must be excluded.
Low
CYP17A1-related diagnosis confirmed
Molecular confirmation separates it from a chromosomal deletion syndrome.
High
How key tests differ
| Test | 5p Partial Monosomy Syndrome C0010314 | 17 20 Lyase Deficiency Isolated Included CN372394 | Interpretation |
|---|---|---|---|
| Karyotype or chromosomal microarray | Deletion involving chromosome 5p may be detected. | No characteristic chromosomal deletion is expected. | A detected deletion supports the left diagnosis; a normal result does not prove the right diagnosis. |
| Steroid pathway evaluation | No specific steroid pattern is established. | Sex-steroid production may be low, with precursor abnormalities interpreted by specialists. | Abnormal results are not diagnostic without clinical and genetic correlation; no cutoff is supplied. |
| CYP17A1 genetic testing | Not the primary confirmatory test. | A pathogenic variant may support the enzyme disorder. | Variant interpretation requires a genetics clinician and does not replace endocrine assessment. |
Prognosis comparison
5p Partial Monosomy Syndrome C0010314
- Outcome
- Usually a lifelong congenital condition with variable developmental support needs.
- Factors
- Deletion extent, associated anomalies, therapies, and medical complications influence outcome.
17 20 Lyase Deficiency Isolated Included CN372394
- Outcome
- Chronic endocrine condition; long-term outcome data are sparse.
- Factors
- Degree of sex-steroid deficiency, associated hormone defects, and timely specialist care matter.
Time frame: Both are chronic; onset is typically infancy on the left and childhood or adolescence may reveal the right.
No reliable mortality or prevalence comparison is established from the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopment | Intellectual disability and developmental delay are characteristic concerns. A primary intellectual disability syndrome is not established. Developmental needs should be assessed individually. |
| Reproductive development | Reproductive endocrine failure is not the defining complication. Hypogonadism, atypical genitalia, or infertility may occur. Phenotype depends on karyotype and residual enzyme activity. |
| Associated congenital problems | Feeding, growth, cardiac, or other congenital issues may occur. Systemic congenital anomalies are not established as typical. Screening should follow clinical findings rather than assumptions. |
Patient education highlights
- HighDifferent causes
One condition is a chromosomal deletion; the other is a rare hormone-production disorder. Neither is contagious.
- HighSpecialist follow-up
Genetics, developmental, and endocrine specialists should interpret results and guide care.
- MediumNo self-diagnosis from one test
An abnormal laboratory or genetic result needs clinical correlation before a diagnosis is made.